Citations (10)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Adoración Navarro-Torné, Eva Agostina Montuori, Vasiliki Kossyvaki & Cristina Méndez. (2021) Burden of pneumococcal disease among adults in Southern Europe (Spain, Portugal, Italy, and Greece): a systematic review and meta-analysis. Human Vaccines & Immunotherapeutics 17:10, pages 3670-3686.
Read now
Read now
Md. Moinuddin Sheam, Shifath Bin Syed, Zulkar Nain, Swee- Seong Tang, Dipak Kumar Paul, Kazi Rejvee Ahmed & Sudhangshu Kumar Biswas. (2020) Community-acquired pneumonia: aetiology, antibiotic resistance and prospects of phage therapy. Journal of Chemotherapy 32:8, pages 395-410.
Read now
Read now
Articles from other publishers (8)
M. Woodhead, F. Blasi, S. Ewig, J. Garau, G. Huchon, M. Ieven, A. Ortqvist, T. Schaberg, A. Torres, G. van der Heijden, R. Read & T.J.M. Verheij. (2011) Guidelines for the management of adult lower respiratory tract infections - Full version. Clinical Microbiology and Infection 17, pages E1-E59.
Crossref
Crossref
M. Woodhead, F. Blasi, S. Ewig, J. Garau, G. Huchon, M. Ieven, A. Ortqvist, T. Schaberg, A. Torres, G. van der Heijden, R. Read & T.J.M. Verheij. (2011) Guidelines for the management of adult lower respiratory tract infections - Summary. Clinical Microbiology and Infection 17, pages 1-24.
Crossref
Crossref
Giordano Madeddu, Alessandro Giuseppe Fois, Pietro Pirina & Maria Stella Mura. (2009) Pneumococcal pneumonia: clinical features, diagnosis and management in HIV-infected and HIV noninfected patients. Current Opinion in Pulmonary Medicine 15:3, pages 236-242.
Crossref
Crossref
Elliott Frank, Jing Liu, Gary Kinasewitz, Gregory J. Moran, Margaret P. Oross, William H. Olson, Veronica Reichl, Susan Freitag, Neelam Bahal, Barbara A. Wiesinger, Alan Tennenberg & James B. Kahn. (2002) A multicenter, open-label, randomized comparison of levofloxacin and azithromycin plus ceftriaxone in hospitalized adults with moderate to severe community-acquired pneumonia. Clinical Therapeutics 24:8, pages 1292-1308.
Crossref
Crossref
C. Krasemann, J. Meyer & G. Tillotson. (2001) Evaluation of the Clinical Microbiology Profile of Moxifloxacin. Clinical Infectious Diseases 32:Supplement 1, pages S51-S63.
Crossref
Crossref
Lorenzo Drago, Barbara Mombelli, Elena De Vecchi, Loredana Tocalli, Giampiero Nardi & Maria Rita Gismondo. (2000) Epidemiology of Gram-negative antibiotic resistance in outpatients: a year of surveillance. International Journal of Antimicrobial Agents 16:4, pages 479-481.
Crossref
Crossref
Julio Ramirez, Joel Unowsky, George H. Talbot, Hao Zhang & Lloyd Townsend. (1999) Sparfloxacin versus clarithromycin in the treatment of community-acquired pneumonia. Clinical Therapeutics 21:1, pages 103-117.
Crossref
Crossref
M. Zervos & M. Nelson. (1998) Cefepime versus Ceftriaxone for Empiric Treatment of Hospitalized Patients with Community-Acquired Pneumonia. Antimicrobial Agents and Chemotherapy 42:4, pages 729-733.
Crossref
Crossref